Immediate Impact

67 standout
Sub-graph 1 of 22

Citing Papers

Current best practice for bladder cancer: a narrative review of diagnostics and treatments
2022 Standout
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
2021 Standout
2 intermediate papers

Works of D. Filipas being referenced

Quality of life in patients with bladder carcinoma after cystectomy: First results of a prospective study
2000

Author Peers

Author Last Decade Papers Cites
D. Filipas 427 361 149 177 30 662
Konstantinos Dimitropoulos 247 247 240 199 49 732
Hari Tunuguntla 356 376 190 382 39 743
Marco Spilotros 318 258 175 153 33 719
William Brannan 336 335 242 151 39 793
Oded Kessler 308 185 163 183 28 639
Stefano De Stefani 380 278 161 269 39 757
Ulrich Witzsch 286 202 406 185 35 751
Giorgio Pomara 294 206 192 148 46 649
F. Travaglini 390 180 251 113 38 778
Gaetano Gulino 294 247 248 222 63 781

All Works

Loading papers...

Rankless by CCL
2026